$VTR
Ventas, Inc. Stock $vtr

$vtr Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000074026023000159 Filed on August 04, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$1.150B	$1.106B
YoY Change	10.85%	8.15%
Cost Of Revenue	$657.9M	$624.3M
YoY Change	15.11%	8.42%
Gross Profit	$491.9M	$482.1M
YoY Change	5.62%	7.81%
Gross Profit Margin	42.78%	43.58%
Selling, General & Admin	$33.30M	$34.40M
YoY Change	-6.0%	4.51%
% of Gross Profit	6.77%	7.14%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$370.4M	$304.7M
YoY Change	22.85%	7.64%
% of Gross Profit	75.3%	63.2%
Operating Expenses	$331.0M	$339.1M
YoY Change	7.18%	11.77%
Operating Profit	$160.9M	$143.0M
YoY Change	2.56%	-0.53%
Interest Expense	$147.9M	-$112.0M
YoY Change	23.87%	-198.3%
% of Operating Profit	91.93%	-78.32%
Other Income/Expense, Net	-$9.432M	$30.02M
YoY Change	2.95%	-162.4%
Pretax Income	-$76.81M	$95.29M
YoY Change	1415.05%	-317.01%
Income Tax	-$1.662M	-$9.773M
% Of Pretax Income		-10.26%
Net Earnings	-$69.56M	$103.5M
YoY Change	-2370.94%	-351.09%
Net Earnings / Revenue	-6.05%	9.35%
Basic Earnings Per Share	-$0.18	$0.26
Diluted Earnings Per Share	-$0.18	$0.26
COMMON SHARES
Basic Shares Outstanding	402.4M shares	400.1M shares
Diluted Shares Outstanding	406.7M shares	404.1M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$433.9M	$138.6M
YoY Change	198.97%	9.11%
Cash & Equivalents	$433.9M	$138.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$433.9M	$138.6M
YoY Change	198.97%	9.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$22.09B	$22.48B
YoY Change	3.81%	3.49%
Goodwill	$1.045B	$1.045B
YoY Change	0.12%	0.06%
Intangibles
YoY Change
Long-Term Investments	$659.2M	$629.2M
YoY Change	8.75%	6.57%
Other Assets	$220.4M	$99.71M
YoY Change	34.73%	8.52%
Total Long-Term Assets	$24.53B	$24.93B
YoY Change	1.56%	1.76%
TOTAL ASSETS
Total Short-Term Assets	$433.9M	$138.6M
Total Long-Term Assets	$24.53B	$24.93B
Total Assets	$24.97B	$25.07B
YoY Change	2.74%	1.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.090B	$1.070B
YoY Change	2.45%	0.63%
Accrued Expenses	$317.4M	$313.8M
YoY Change	11.53%	5.05%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.407B	$1.383B
YoY Change	4.37%	1.6%
LONG-TERM LIABILITIES
Long-Term Debt	$13.39B	$13.35B
YoY Change	9.64%	8.33%
Other Long-Term Liabilities	$5.098M	$2.959M
YoY Change	-46.29%	-49.6%
Total Long-Term Liabilities	$13.39B	$13.36B
YoY Change	9.6%	8.3%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.407B	$1.383B
Total Long-Term Liabilities	$13.39B	$13.36B
Total Liabilities	$14.83B	$14.83B
YoY Change	8.95%	7.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.941B	-$5.688B
YoY Change	13.73%	12.76%
Common Stock	$15.78B	$15.69B
YoY Change	0.93%	0.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.818B	$10.24B
YoY Change
Total Liabilities & Shareholders Equity	$24.97B	$25.07B
YoY Change	2.74%	1.8%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$69.56M	$103.5M
YoY Change	-2370.94%	-351.09%
Depreciation, Depletion And Amortization	$370.4M	$304.7M
YoY Change	22.85%	7.64%
Cash From Operating Activities	$286.1M	$311.8M
YoY Change	-4.71%	12.14%
INVESTING ACTIVITIES
Capital Expenditures	$158.9M	$128.4M
YoY Change	-245.98%	-230.3%
Acquisitions
YoY Change
Other Investing Activities	$145.1M	$57.10M
YoY Change	-353.78%	-344.31%
Cash From Investing Activities	-$13.78M	-$71.33M
YoY Change	-91.7%	-41.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	9.791M	-226.0M
YoY Change	-108.74%	26.72%
NET CHANGE
Cash From Operating Activities	286.1M	311.8M
Cash From Investing Activities	-13.78M	-71.33M
Cash From Financing Activities	9.791M	-226.0M
Net Change In Cash	282.2M	14.52M
YoY Change	1170.57%	-165.46%
FREE CASH FLOW
Cash From Operating Activities	$286.1M	$311.8M
Capital Expenditures	$158.9M	$128.4M
Free Cash Flow	$127.2M	$183.4M
YoY Change	-68.91%	-51.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	400620000	shares
CY2023Q2	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	1436000	usd
CY2022Q2	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	1410000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	17959000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-48116000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	1043724000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	1066849000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	62634000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43911000	usd
CY2023Q2	vtr	Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree	31254000	usd
CY2022Q2	vtr	Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree	-1047000	usd
CY2023Q2	vtr	Gain Loss On Disposition Of Real Estate GainLossOnDispositionOfRealEstate	1405000	usd
CY2022Q2	vtr	Gain Loss On Disposition Of Real Estate GainLossOnDispositionOfRealEstate	-34000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9773000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3790000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	105066000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-41202000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.26
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10028444000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.26
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2023Q2	us-gaap	Profit Loss ProfitLoss	105066000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1881000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	28001000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	134948000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	5578000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	129370000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10064602000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	105066000	usd
CY2023Q2	vtr	Noncontrolling Interest Period Increase Decrease Including Impact To Equity NoncontrollingInterestPeriodIncreaseDecreaseIncludingImpactToEquity	9664000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.45
CY2023Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	180875000	usd
CY2023Q2	vtr	Stock Issued During Period Value Share Based Payment Arrangements Restricted Stock Awards And Other After Forfeiture StockIssuedDuringPeriodValueShareBasedPaymentArrangementsRestrictedStockAwardsAndOtherAfterForfeiture	30443000	usd
CY2023Q2	vtr	Adjustments To Additional Paid In Capital Related To Redeemable Operating Partner Unitholder Interests To Record At Fair Value AdjustmentsToAdditionalPaidInCapitalRelatedToRedeemableOperatingPartnerUnitholderInterestsToRecordAtFairValue	-11010000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-41202000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1147000	usd
CY2022Q2	vtr	Noncontrolling Interest Period Increase Decrease Including Impact To Equity NoncontrollingInterestPeriodIncreaseDecreaseIncludingImpactToEquity	11285000	usd
CY2022Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.45
CY2022Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	180500000	usd
CY2022Q2	vtr	Stock Issued During Period Value Share Based Payment Arrangements Restricted Stock Awards And Other After Forfeiture StockIssuedDuringPeriodValueShareBasedPaymentArrangementsRestrictedStockAwardsAndOtherAfterForfeiture	9499000	usd
CY2022Q2	vtr	Adjustments To Additional Paid In Capital Related To Redeemable Operating Partner Unitholder Interests To Record At Fair Value AdjustmentsToAdditionalPaidInCapitalRelatedToRedeemableOperatingPartnerUnitholderInterestsToRecordAtFairValue	33045000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10603394000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10221677000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3008000	usd
	us-gaap	Profit Loss ProfitLoss	123978000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	24979000	usd
	vtr	Noncontrolling Interest Period Increase Decrease Including Impact To Equity NoncontrollingInterestPeriodIncreaseDecreaseIncludingImpactToEquity	9530000	usd
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.90
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	360074000	usd
	vtr	Stock Issued During Period Value Share Based Payment Arrangements Restricted Stock Awards And Other After Forfeiture StockIssuedDuringPeriodValueShareBasedPaymentArrangementsRestrictedStockAwardsAndOtherAfterForfeiture	35416000	usd
	vtr	Adjustments To Additional Paid In Capital Related To Redeemable Operating Partner Unitholder Interests To Record At Fair Value AdjustmentsToAdditionalPaidInCapitalRelatedToRedeemableOperatingPartnerUnitholderInterestsToRecordAtFairValue	-7933000	usd
	vtr	Adjustments To Equity Redemption Of Limited Partnership Units AdjustmentsToEquityRedemptionOfLimitedPartnershipUnits	-69000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10028444000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10945760000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3074000	usd
	us-gaap	Profit Loss ProfitLoss	-610000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	10282000	usd
	vtr	Noncontrolling Interest Period Increase Decrease Including Impact To Equity NoncontrollingInterestPeriodIncreaseDecreaseIncludingImpactToEquity	12289000	usd
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.90
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	360996000	usd
	vtr	Stock Issued During Period Value Share Based Payment Arrangements Restricted Stock Awards And Other After Forfeiture StockIssuedDuringPeriodValueShareBasedPaymentArrangementsRestrictedStockAwardsAndOtherAfterForfeiture	24839000	usd
	vtr	Adjustments To Additional Paid In Capital Related To Redeemable Operating Partner Unitholder Interests To Record At Fair Value AdjustmentsToAdditionalPaidInCapitalRelatedToRedeemableOperatingPartnerUnitholderInterestsToRecordAtFairValue	-3592000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10603394000	usd
	us-gaap	Profit Loss ProfitLoss	123978000	usd
	us-gaap	Profit Loss ProfitLoss	-610000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	586808000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	572139000	usd
	vtr	Amortization Of Deferred Revenue And Lease Intangibles AmortizationOfDeferredRevenueAndLeaseIntangibles	-29592000	usd
	vtr	Amortization Of Deferred Revenue And Lease Intangibles AmortizationOfDeferredRevenueAndLeaseIntangibles	-33491000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	8969000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	6412000	usd
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-20129000	usd
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-116000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	20389000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	22601000	usd
	us-gaap	Straight Line Rent StraightLineRent	1884000	usd
	us-gaap	Straight Line Rent StraightLineRent	7559000	usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	6801000	usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-7000	usd
	vtr	Gain Loss On Disposition Of Real Estate GainLossOnDispositionOfRealEstate	11606000	usd
	vtr	Gain Loss On Disposition Of Real Estate GainLossOnDispositionOfRealEstate	2421000	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-15813000	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-11184000	usd
	vtr	Gain Loss From Equity Method Investments And Other Items Non Cash Portion GainLossFromEquityMethodInvestmentsAndOtherItemsNonCashPortion	25618000	usd
	vtr	Gain Loss From Equity Method Investments And Other Items Non Cash Portion GainLossFromEquityMethodInvestmentsAndOtherItemsNonCashPortion	-5322000	usd
	vtr	Gain Loss From Real Estate Operations Foreclosure GainLossFromRealEstateOperationsForeclosure	29127000	usd
	vtr	Gain Loss From Real Estate Operations Foreclosure GainLossFromRealEstateOperationsForeclosure	0	usd
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	9682000	usd
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	10719000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	14279000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-25128000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	17341000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	32622000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-3524000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-2008000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-19468000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	315000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	554644000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	552632000	usd
	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	977000	usd
	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	388295000	usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	589000	usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	5225000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	64405000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	6171000	usd
	us-gaap	Proceeds From Sale And Collection Of Loans Receivable ProceedsFromSaleAndCollectionOfLoansReceivable	43822000	usd
	us-gaap	Proceeds From Sale And Collection Of Loans Receivable ProceedsFromSaleAndCollectionOfLoansReceivable	487000	usd
	us-gaap	Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates	50054000	usd
	us-gaap	Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates	0	usd
	vtr	Proceeds From Real Estate Operations Foreclosure ProceedsFromRealEstateOperationsForeclosure	11615000	usd
	vtr	Proceeds From Real Estate Operations Foreclosure ProceedsFromRealEstateOperationsForeclosure	0	usd
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	144809000	usd
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	81878000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	96271000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	91004000	usd
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	usd
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	25652000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	64247000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	33086000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	9390000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	7918000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-127607000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-559260000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	8293000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-7822000	usd
	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	-267414000	usd
	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	55184000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1748532000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	706915000	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	1489112000	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	394395000	usd
	vtr	Payments For Noncontrolling Interests PaymentsForNoncontrollingInterests	110000	usd
	vtr	Payments For Noncontrolling Interests PaymentsForNoncontrollingInterests	170000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	27356000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	4126000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25007000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	361703000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	360098000	usd
	vtr	Cash Distributions To Redeemable Op Unitholders CashDistributionsToRedeemableOPUnitholders	3089000	usd
	vtr	Cash Distributions To Redeemable Op Unitholders CashDistributionsToRedeemableOPUnitholders	3072000	usd
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	655000	usd
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	0	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	7979000	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	39000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	17388000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	7873000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1736000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8691000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-12805000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-6219000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-388085000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12946000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	38952000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-19574000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	650000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-992000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	170745000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	196597000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	210347000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	176031000	usd
	us-gaap	Transfer Of Investments TransferOfInvestments	0	usd
	us-gaap	Transfer Of Investments TransferOfInvestments	3176000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	7873000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	362000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	9000000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	2944000	usd
	vtr	Noncash Or Part Noncash Acquisition Deferred Income Tax Liabilities Assumed NoncashOrPartNoncashAcquisitionDeferredIncomeTaxLiabilitiesAssumed	12382000	usd
	vtr	Noncash Or Part Noncash Acquisition Deferred Income Tax Liabilities Assumed NoncashOrPartNoncashAcquisitionDeferredIncomeTaxLiabilitiesAssumed	594000	usd
	vtr	Settlements Of Loans Receivable SettlementsOfLoansReceivable	486082000	usd
	vtr	Settlements Of Loans Receivable SettlementsOfLoansReceivable	0	usd
	vtr	Settlements Of Loans Receivable Real Estate Received SettlementsOfLoansReceivableRealEstateReceived	1566395000	usd
	vtr	Settlements Of Loans Receivable Real Estate Received SettlementsOfLoansReceivableRealEstateReceived	0	usd
	vtr	Real Estate Owned Debt Assumed RealEstateOwnedDebtAssumed	1016804000	usd
	vtr	Real Estate Owned Debt Assumed RealEstateOwnedDebtAssumed	0	usd
	us-gaap	Nature Of Operations NatureOfOperations	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1—DESCRIPTION OF BUSINESS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ventas, Inc. (together with its consolidated subsidiaries, unless otherwise indicated or except where the context otherwise requires, “we,” “us,” “our,” “Company” and other similar terms), an S&P 500 company, is a real estate investment trust (“REIT”) operating at the intersection of healthcare and real estate. We hold a highly diversified portfolio of senior housing communities, outpatient medical buildings, research centers, hospitals and other healthcare facilities, which we generally refer to collectively as “healthcare real estate,” located throughout the United States, Canada and the United Kingdom. As of June 30, 2023, we owned or had investments in approximately 1,400 properties (including properties classified as held for sale). Our company was originally founded in 1983 and is headquartered in Chicago, Illinois with additional corporate offices in Louisville, Kentucky and New York, New York. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily invest in a diversified portfolio of healthcare real estate assets through wholly owned subsidiaries and other co-investment entities. We operate through three reportable business segments: triple-net leased properties, senior housing operating portfolio, which we also refer to as “SHOP” and which was formerly known as senior living operations, and outpatient medical and research portfolio, which was formerly known as office operations. See “Note 2 – Accounting Policies” and “Note 15 – Segment Information.” Our senior housing communities are either subject to triple-net leases, in which case they are included in our triple-net leased properties reportable business segment, or operated by independent third-party managers, in which case they are included in our SHOP reportable business segment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023, we leased a total of 355 properties (excluding properties within our outpatient medical and research portfolio reportable business segment) to various healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses, including maintenance, utilities, repairs, taxes, insurance and capital expenditures. Our three largest tenants, Brookdale Senior Living Inc. (together with its subsidiaries, “Brookdale Senior Living”), Ardent Health Partners, LLC (together with its subsidiaries, “Ardent”) and Kindred Healthcare, LLC (together with its subsidiaries, “Kindred”) leased from us 121 properties, 30 properties (including 19 outpatient medical buildings) and 29 properties, respectively, as of June 30, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023, pursuant to long-term management agreements, we engaged independent operators, such as Atria Senior Living, Inc. (together with its subsidiaries, including Holiday Retirement (“Holiday”), “Atria”) and Sunrise Senior Living, LLC (together with its subsidiaries, “Sunrise”), to manage 579 senior housing communities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023, we owned or had investments in a total of 460 properties in our outpatient medical and research portfolio reportable business segment. These properties generally consist of outpatient medical buildings that are predominantly located on or contiguous to a health system campus and research properties that are affiliated with and often located on or contiguous to a university or academic medical campus. Through our Lillibridge Healthcare Services, Inc. subsidiary and our ownership interest in PMB Real Estate Services LLC, we also provide outpatient medical building management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time, we make secured and unsecured loans and other investments relating to healthcare real estate or operators. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a third-party institutional capital management business, Ventas Investment Management (“VIM”), which includes our open-ended investment vehicle, the Ventas Life Science & Healthcare Real Estate Fund (the “Ventas Fund”). Through VIM, we partner with third-party institutional investors to invest in healthcare real estate through various joint ventures and other co-investment vehicles where we are the sponsor or general partner.</span></div>
CY2023Q2	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	1400	property
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q2	vtr	Concentration Risk Number Of Tenants ConcentrationRiskNumberOfTenants	3	tenant
	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with GAAP requires us to make estimates and assumptions regarding future events that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	11600000	usd
CY2023Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	21027000	usd
CY2023Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	2959000	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	44893000	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	6492000	usd
CY2023Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	10700000	usd
CY2022Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	12600000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	19200000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	26900000	usd
CY2023Q2	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities	52200000	usd
CY2022Q4	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities	561400000	usd
CY2023Q2	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities Amortized Cost SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesAmortizedCost	56741000	usd
CY2023Q2	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss DebtSecuritiesHeldToMaturityAllowanceForCreditLoss	4492000	usd
CY2023Q2	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities	52249000	usd
CY2023Q2	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities Fair Value SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesFairValue	51416000	usd
CY2022Q4	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities Amortized Cost SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesAmortizedCost	586034000	usd
CY2022Q4	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss DebtSecuritiesHeldToMaturityAllowanceForCreditLoss	24621000	usd
CY2022Q4	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities Fair Value SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesFairValue	560449000	usd
CY2023Q1	vtr	Debt Securities Held To Maturity And Available For Sale Allowance For Credit Loss DebtSecuritiesHeldToMaturityAndAvailableForSaleAllowanceForCreditLoss	12000000	usd
CY2023Q2	vtr	Debt Securities Held To Maturity And Available For Sale Impact Of Loan Settlement Or Foreclosure DebtSecuritiesHeldToMaturityAndAvailableForSaleImpactOfLoanSettlementOrForeclosure	41100000	usd
CY2023Q2	vtr	Debt Securities Held To Maturity And Available For Sale Credit Loss Expense Reversal DebtSecuritiesHeldToMaturityAndAvailableForSaleCreditLossExpenseReversal	-12000000	usd
	vtr	Debt Securities Held To Maturity And Available For Sale Credit Loss Expense Reversal DebtSecuritiesHeldToMaturityAndAvailableForSaleCreditLossExpenseReversal	-20000000	usd
CY2023Q2	vtr	Gain Loss From Real Estate Operations Foreclosure GainLossFromRealEstateOperationsForeclosure	29100000	usd
	vtr	Gain Loss From Real Estate Operations Foreclosure GainLossFromRealEstateOperationsForeclosure	29100000	usd
CY2023Q2	us-gaap	Real Estate Investments RealEstateInvestments	626230000	usd
CY2022Q4	us-gaap	Real Estate Investments RealEstateInvestments	579949000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	50100000	usd
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	33500000	usd
CY2023Q2	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	33500000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	1045147000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1044415000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1137288000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1061305000	usd
CY2023Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1440939000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P7Y1M6D
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1363704000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P7Y9M18D
CY2023Q2	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	342741000	usd
	vtr	Finite Lived Intangible Liabilities Below Market Leases Remaining Weighted Average Amortization Period FiniteLivedIntangibleLiabilitiesBelowMarketLeasesRemainingWeightedAverageAmortizationPeriod	P7Y8M12D
CY2022Q4	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	333672000	usd
CY2022	vtr	Finite Lived Intangible Liabilities Below Market Leases Remaining Weighted Average Amortization Period FiniteLivedIntangibleLiabilitiesBelowMarketLeasesRemainingWeightedAverageAmortizationPeriod	P8Y7M6D
CY2023Q2	vtr	Other Finite Lived Intangible Liabilities Gross OtherFiniteLivedIntangibleLiabilitiesGross	13498000	usd
CY2022Q4	vtr	Other Finite Lived Intangible Liabilities Gross OtherFiniteLivedIntangibleLiabilitiesGross	13498000	usd
CY2023Q2	vtr	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	261079000	usd
CY2022Q4	vtr	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	258639000	usd
CY2023Q2	vtr	Indefinite Lived Intangible Liabilities Purchase Options IndefiniteLivedIntangibleLiabilitiesPurchaseOptions	3568000	usd
CY2022Q4	vtr	Indefinite Lived Intangible Liabilities Purchase Options IndefiniteLivedIntangibleLiabilitiesPurchaseOptions	3568000	usd
CY2023Q2	vtr	Finite And Indefinite Lived Intangible Liabilities Net FiniteAndIndefiniteLivedIntangibleLiabilitiesNet	98728000	usd
	vtr	Finite Lived Intangible Liabilities Remaining Weighted Average Amortization Period FiniteLivedIntangibleLiabilitiesRemainingWeightedAverageAmortizationPeriod	P7Y8M12D
CY2022Q4	vtr	Finite And Indefinite Lived Intangible Liabilities Net FiniteAndIndefiniteLivedIntangibleLiabilitiesNet	92099000	usd
CY2022	vtr	Finite Lived Intangible Liabilities Remaining Weighted Average Amortization Period FiniteLivedIntangibleLiabilitiesRemainingWeightedAverageAmortizationPeriod	P8Y7M6D
CY2023Q2	vtr	Deferred Rent Receivable DeferredRentReceivable	193583000	usd
CY2022Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	187536000	usd
CY2023Q2	vtr	Non Mortgage Loans Receivable Net NonMortgageLoansReceivableNet	24500000	usd
CY2022Q4	vtr	Non Mortgage Loans Receivable Net NonMortgageLoansReceivableNet	24338000	usd
CY2023Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5997000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	6393000	usd
CY2023Q2	vtr	Investment In Unconsolidated Operating Entities InvestmentInUnconsolidatedOperatingEntities	79417000	usd
CY2022Q4	vtr	Investment In Unconsolidated Operating Entities InvestmentInUnconsolidatedOperatingEntities	95363000	usd
CY2023Q2	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	303371000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	272572000	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	647319000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	609823000	usd
CY2023Q2	us-gaap	Commercial Paper CommercialPaper	135000000	usd
CY2022Q4	us-gaap	Commercial Paper CommercialPaper	403000000	usd
CY2023Q2	vtr	Long Term Debt And Short Term Borrowings Gross LongTermDebtAndShortTermBorrowingsGross	13438942000	usd
CY2022Q4	vtr	Long Term Debt And Short Term Borrowings Gross LongTermDebtAndShortTermBorrowingsGross	12361244000	usd
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	81363000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	63410000	usd
CY2023Q2	vtr	Debt Instrument Unamortized Fair Value Adjustment DebtInstrumentUnamortizedFairValueAdjustment	19510000	usd
CY2022Q4	vtr	Debt Instrument Unamortized Fair Value Adjustment DebtInstrumentUnamortizedFairValueAdjustment	23535000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	22349000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	24589000	usd
CY2023Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	13354740000	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	12296780000	usd
CY2023Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	14700000	usd
CY2023Q2	vtr	Commercial Paper Program Capacity CommercialPaperProgramCapacity	1000000000	usd
CY2023Q2	us-gaap	Commercial Paper CommercialPaper	135000000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	132629000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1680338000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2241611000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1951619000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1380325000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	6052420000	usd
CY2023Q2	vtr	Long Term Debt And Short Term Borrowings Gross LongTermDebtAndShortTermBorrowingsGross	13438942000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	138600000	usd
CY2023Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	50000000	usd
CY2023Q2	us-gaap	Derivative Term Of Contract DerivativeTermOfContract	P10Y
CY2023Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0317
CY2023Q2	vtr	Long Term Debt And Short Term Borrowings Gross LongTermDebtAndShortTermBorrowingsGross	13438942000	usd
CY2022Q4	vtr	Long Term Debt And Short Term Borrowings Gross LongTermDebtAndShortTermBorrowingsGross	12361244000	usd
	vtr	Settlements Of Loans Receivable Real Estate Received SettlementsOfLoansReceivableRealEstateReceived	1566000000	usd
	vtr	Loans Receivable Real Estate Received Capital Improvements LoansReceivableRealEstateReceivedCapitalImprovements	31800000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9800000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3800000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12600000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8300000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	2000000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	29700000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	35600000	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	7000000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	10500000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-56997000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-60364000	usd
CY2023Q2	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	42445000	usd
CY2022Q4	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	23564000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14552000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-36800000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	105066000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-41202000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	123978000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-610000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	105066000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-41202000	usd
	us-gaap	Profit Loss ProfitLoss	123978000	usd
	us-gaap	Profit Loss ProfitLoss	-610000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1613000	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1214000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3008000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3074000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	103453000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-42416000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	120970000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3684000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	400431000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	399592000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	400211000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	399445000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	41000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	33000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	220000	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	376000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	268000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	398000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	3471000	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	3517000	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	3478000	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	3517000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	404122000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	403526000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	403957000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	403393000	shares
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.26
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.10
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.31
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.26
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.10
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.31
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
	vtr	Intersegment Sales And Transfers IntersegmentSalesAndTransfers	0	usd
CY2023Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	370162000	usd
CY2023Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	6554000	usd
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	1032000	usd
CY2023Q2	us-gaap	Revenues Revenues	1106358000	usd
CY2023Q2	us-gaap	Revenues Revenues	1106358000	usd
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	1032000	usd
CY2023Q2	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	622818000	usd
CY2023Q2	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	1436000	usd
CY2023Q2	vtr	Net Operating Income NetOperatingIncome	481072000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	143265000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	304689000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34399000	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	6801000	usd
CY2023Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3069000	usd
CY2023Q2	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	-12065000	usd
CY2023Q2	vtr	Gain Loss From Real Estate Operations Foreclosure GainLossFromRealEstateOperationsForeclosure	29127000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	17959000	usd
CY2023Q2	vtr	Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree	31254000	usd
CY2023Q2	vtr	Gain Loss On Disposition Of Real Estate GainLossOnDispositionOfRealEstate	1405000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9773000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	105066000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	105066000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1613000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	103453000	usd
CY2022Q2	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	348638000	usd
CY2022Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	10752000	usd
CY2022Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	1166000	usd
CY2022Q2	us-gaap	Revenues Revenues	1022938000	usd
CY2022Q2	us-gaap	Revenues Revenues	1022938000	usd
CY2022Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	1166000	usd
CY2022Q2	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	574359000	usd
CY2022Q2	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	1410000	usd
CY2022Q2	vtr	Net Operating Income NetOperatingIncome	446003000	usd
CY2022Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	1166000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	113951000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	283075000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32915000	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7000	usd
CY2022Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	13078000	usd
CY2022Q2	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	-62000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-48116000	usd
CY2022Q2	vtr	Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree	-1047000	usd
CY2022Q2	vtr	Gain Loss On Disposition Of Real Estate GainLossOnDispositionOfRealEstate	-34000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3790000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-41202000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-41202000	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1214000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-42416000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	722905000	usd
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	20143000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	2775000	usd
	us-gaap	Revenues Revenues	2183603000	usd
	us-gaap	Revenues Revenues	2183603000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	2775000	usd
	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	1230749000	usd
	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	3142000	usd
	vtr	Net Operating Income NetOperatingIncome	946937000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	2775000	usd
	us-gaap	Interest Expense InterestExpense	271340000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	586808000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	79197000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	6801000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	4455000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	-20129000	usd
	vtr	Gain Loss From Real Estate Operations Foreclosure GainLossFromRealEstateOperationsForeclosure	29127000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10197000	usd
	vtr	Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree	25631000	usd
	vtr	Gain Loss On Disposition Of Real Estate GainLossOnDispositionOfRealEstate	11606000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12575000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	123978000	usd
	us-gaap	Profit Loss ProfitLoss	123978000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3008000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	120970000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	700739000	usd
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	20599000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	1702000	usd
	us-gaap	Revenues Revenues	2040492000	usd
	us-gaap	Revenues Revenues	2040492000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	1702000	usd
	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	1117080000	usd
	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	2723000	usd
	vtr	Net Operating Income NetOperatingIncome	918987000	usd
	us-gaap	Interest Expense InterestExpense	224745000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	572139000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	75913000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	33070000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	-116000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-20926000	usd
	vtr	Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree	-5316000	usd
	vtr	Gain Loss On Disposition Of Real Estate GainLossOnDispositionOfRealEstate	2421000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8280000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-610000	usd
	us-gaap	Profit Loss ProfitLoss	-610000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3074000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3684000	usd
CY2023Q2	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	129401000	usd
CY2022Q2	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	143066000	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	242057000	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	561177000	usd
CY2023Q2	us-gaap	Revenues Revenues	1106358000	usd
CY2022Q2	us-gaap	Revenues Revenues	1022938000	usd
	us-gaap	Revenues Revenues	2183603000	usd
	us-gaap	Revenues Revenues	2040492000	usd
CY2023Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	22483109000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	21160450000	usd

Files In Submission

Name	View Source	Status
0000740260-23-000159-index-headers.html	Edgar Link	pending
0000740260-23-000159-index.html	Edgar Link	pending
0000740260-23-000159.txt	Edgar Link	pending
0000740260-23-000159-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vtr-20230630.htm	Edgar Link	pending
vtr-20230630.xsd	Edgar Link	pending
vtr-ex101_063023.htm	Edgar Link	pending
vtr-ex22_063023.htm	Edgar Link	pending
vtr-ex311_063023.htm	Edgar Link	pending
vtr-ex312_063023.htm	Edgar Link	pending
vtr-ex321_063023.htm	Edgar Link	pending
vtr-ex322_063023.htm	Edgar Link	pending
vtr-20230630_def.xml	Edgar Link	unprocessable
vtr-20230630_lab.xml	Edgar Link	unprocessable
vtr-20230630_pre.xml	Edgar Link	unprocessable
vtr-20230630_htm.xml	Edgar Link	completed
vtr-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VTR
Ventas, Inc. Stock $vtr

2023 Q3 Form 10-Q Financial Statement

#000074026023000159 Filed on August 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VTR Ventas, Inc. Stock $vtr

2023 Q3 Form 10-Q Financial Statement

#000074026023000159 Filed on August 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VTR
Ventas, Inc. Stock $vtr